1. Home
  2. PLRX vs SPTN Comparison

PLRX vs SPTN Comparison

Compare PLRX & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • SPTN
  • Stock Information
  • Founded
  • PLRX 2015
  • SPTN 1917
  • Country
  • PLRX United States
  • SPTN United States
  • Employees
  • PLRX N/A
  • SPTN N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • SPTN Food Distributors
  • Sector
  • PLRX Health Care
  • SPTN Consumer Discretionary
  • Exchange
  • PLRX Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • PLRX 682.2M
  • SPTN 618.4M
  • IPO Year
  • PLRX 2020
  • SPTN N/A
  • Fundamental
  • Price
  • PLRX $10.92
  • SPTN $17.92
  • Analyst Decision
  • PLRX Strong Buy
  • SPTN Hold
  • Analyst Count
  • PLRX 7
  • SPTN 1
  • Target Price
  • PLRX $40.50
  • SPTN $20.00
  • AVG Volume (30 Days)
  • PLRX 473.9K
  • SPTN 258.9K
  • Earning Date
  • PLRX 02-26-2025
  • SPTN 02-13-2025
  • Dividend Yield
  • PLRX N/A
  • SPTN 4.85%
  • EPS Growth
  • PLRX N/A
  • SPTN 9.92
  • EPS
  • PLRX N/A
  • SPTN 1.33
  • Revenue
  • PLRX N/A
  • SPTN $9,532,883,000.00
  • Revenue This Year
  • PLRX N/A
  • SPTN N/A
  • Revenue Next Year
  • PLRX N/A
  • SPTN $2.15
  • P/E Ratio
  • PLRX N/A
  • SPTN $13.42
  • Revenue Growth
  • PLRX N/A
  • SPTN N/A
  • 52 Week Low
  • PLRX $10.22
  • SPTN $17.30
  • 52 Week High
  • PLRX $18.92
  • SPTN $23.00
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 36.45
  • SPTN 43.03
  • Support Level
  • PLRX $10.68
  • SPTN $17.68
  • Resistance Level
  • PLRX $11.40
  • SPTN $18.38
  • Average True Range (ATR)
  • PLRX 0.71
  • SPTN 0.38
  • MACD
  • PLRX -0.14
  • SPTN 0.04
  • Stochastic Oscillator
  • PLRX 7.92
  • SPTN 57.41

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: